Astrid L.
- Country
- France
- Department
- Hepato_Gastro_Enterology
Research Overview
- Evaluation of Oxaliplatin-Based Chemotherapy for Lean Body Mass Normalization in Patients with Colon Cancer
- Phase III Randomized Study of Induction Chemotherapy with Modified DCF Regimen Followed by Chemoradiotherapy vs. Standard Chemoradiotherapy in Locally Advanced Anal Squamous Cell Carcinoma
- Phase II Randomized Study of Ramucirumab with or without Paclitaxel in Elderly Patients with Metastatic Gastric Cancer
Data & Insights
Has run more than one trial at 159 of 396 partner sites.
Specializations
Gastrointestinal Oncology
Specializes in treating gastric and gastroesophageal junction cancers, with particular focus on advanced therapeutic approaches for both resectable and metastatic disease stages.
- Gastric Adenocarcinoma
- HER2-Positive Gastric Cancer
- Esophageal Cancer Management
Investigates innovative treatment combinations including immunotherapy and targeted therapies for gastrointestinal malignancies.
Colorectal Cancer Research
Focuses on advanced treatments for metastatic colorectal cancer, including targeted therapeutic approaches and immunotherapy strategies.
- Microsatellite Instability Status
- Targeted Therapy Applications
- Combination Treatment Protocols
Explores personalized treatment approaches based on genetic markers and therapeutic monitoring.
Specialized Cancer Areas
Conducts research in biliary tract carcinoma and anal canal squamous cell carcinoma, developing new treatment protocols.
- Pancreatic Adenocarcinoma
- Locally Advanced Anal Cancer
- Adjuvant Therapy Strategies
Evaluates novel therapeutic combinations including immunotherapy and chemotherapy regimens.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.